Latest Cost Management News

Excite Technology Services has reported its highest-ever quarterly customer receipts of $6.3 million, driven by strong growth across its cybersecurity, digital forensics, and IT services divisions. The company also secured a significant $676,000 Federal Government contract and completed its NANGU Tactical Centre.

Stonehorse Energy Limited reported steady Q2 2025 results, driven by strong Canadian production despite lower commodity prices and operational setbacks in the US. The company also announced a strategic board appointment as it pursues growth opportunities.

IMEXHS Limited reported steady Q2 FY25 revenue with an 11% rise in annual recurring revenue, supported by a $2.6 million capital raise and operational advances including a major Mexican contract win.

TerraCom reported steady coal sales for the June quarter despite softer thermal coal prices and weather disruptions, opting to withhold dividends while advancing key projects.

Cann Group Limited delivered record production and revenue growth in Q4 FY2025, securing new funding and advancing a major debt restructuring to set the stage for profitability in FY2026.

Fin Resources Limited is gearing up for a key geophysical survey at its McKenzie Springs copper-nickel-cobalt project while securing $445,000 in funding through convertible notes amid challenging market conditions.

Freehill Mining Ltd reported a challenging quarter ending June 2025 with net cash outflows from operations, but anticipates improved revenues from its Chilean operations as it ramps up activity.

Activeport Group Ltd reported a strong Q4 FY25 with significant revenue growth in software and Network as a Service segments, underpinned by new contracts with leading telecom providers and improved cash flow management.

Bastion Minerals has resumed ASX trading under a refreshed leadership team, announcing a JORC-compliant resource at its ICE Copper-Gold Project and completing multiple capital raises to support its renewed exploration focus.

Hydralyte USA reported an 8.5% rise in Q2 FY25 net sales, driven by strong May performance and improved margins, while preparing to launch new brain and gut health products.

Medical Developments International (MVP) reports positive operating cash flow in H2 FY25, driven by strong Penthrox sales and strategic distribution shifts in Europe. The company eyes further growth amid regulatory progress and efficiency gains.

Resonance Health reports a solid quarter with key clinical trial milestones, expansion of trial sites, and multi-year Software-as-a-Medical Device contracts, underpinning a positive cashflow outlook.